Fig. 2From: SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomyFour CpG sites (cg06480736, cg19774478, cg19788741, cg22149516) methylation level (Beta value) of SLCO4C1 in tumor (PC) and normal tissue (NAT)Back to article page